BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34990518)

  • 21. An alginate-based platform for cancer stem cell research.
    Qiao SP; Zhao YF; Li CF; Yin YB; Meng QY; Lin FH; Liu Y; Hou XL; Guo K; Chen XB; Tian WM
    Acta Biomater; 2016 Jun; 37():83-92. PubMed ID: 27109764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GSH-activatable camptothecin prodrug-loaded gold nanostars coated with hyaluronic acid for targeted breast cancer therapy
    Hou Y; Sun B; Li R; Meng W; Zhang W; Jia N; Chen M; Chen J; Tang X
    J Mater Chem B; 2023 Oct; 11(41):9894-9911. PubMed ID: 37830402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced targeting of invasive glioblastoma cells by peptide-functionalized gold nanorods in hydrogel-based 3D cultures.
    Gonçalves DPN; Rodriguez RD; Kurth T; Bray LJ; Binner M; Jungnickel C; Gür FN; Poser SW; Schmidt TL; Zahn DRT; Androutsellis-Theotokis A; Schlierf M; Werner C
    Acta Biomater; 2017 Aug; 58():12-25. PubMed ID: 28576716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Esculentoside A suppresses breast cancer stem cell growth through stemness attenuation and apoptosis induction by blocking IL-6/STAT3 signaling pathway.
    Liu C; Dong L; Sun Z; Wang L; Wang Q; Li H; Zhang J; Wang X
    Phytother Res; 2018 Nov; 32(11):2299-2311. PubMed ID: 30080291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer.
    Liu HN; Guo NN; Guo WW; Huang-Fu MY; Vakili MR; Chen JJ; Xu WH; Wei QC; Han M; Lavasanifar A; Gao JQ
    Acta Pharmacol Sin; 2018 Oct; 39(10):1681-1692. PubMed ID: 29849132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dodecyl-TPP Targets Mitochondria and Potently Eradicates Cancer Stem Cells (CSCs): Synergy With FDA-Approved Drugs and Natural Compounds (Vitamin C and Berberine).
    De Francesco EM; Ózsvári B; Sotgia F; Lisanti MP
    Front Oncol; 2019; 9():615. PubMed ID: 31440463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD271 antibody-functionalized HGNs for targeted photothermal therapy of osteosarcoma stem cells.
    Tian J; Gu Y; Li Y; Liu T
    Nanotechnology; 2020 Jul; 31(30):305707. PubMed ID: 32235073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds.
    Ózsvári B; Sotgia F; Lisanti MP
    Aging (Albany NY); 2020 May; 12(11):10162-10179. PubMed ID: 32452826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cascade-responsive nano-assembly for efficient photothermal-chemo synergistic inhibition of tumor metastasis by targeting cancer stem cells.
    Zhu X; Li L; Tang J; Yang C; Yu H; Liu K; Zheng Z; Gu X; Yu Q; Xu FJ; Gan Z
    Biomaterials; 2022 Jan; 280():121305. PubMed ID: 34890970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction Therapy of Retinoic Acid with a Temozolomide-Loaded Gold Nanoparticle-Associated Ultrasound Effect on Glioblastoma Cancer Stem-Like Colonies.
    Fadera S; Chen PY; Liu HL; Lee IC
    ACS Appl Mater Interfaces; 2021 Jul; 13(28):32845-32855. PubMed ID: 34235925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using SV119-gold nanocage conjugates to eradicate cancer stem cells through a combination of photothermal and chemo therapies.
    Sun T; Wang Y; Wang Y; Xu J; Zhao X; Vangveravong S; Mach RH; Xia Y
    Adv Healthc Mater; 2014 Aug; 3(8):1283-91. PubMed ID: 24677807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
    Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
    Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversing Resistance of Cancer Stem Cells and Enhancing Photodynamic Therapy Based on Hyaluronic Acid Nanomicelles for Preventing Cancer Recurrence and Metastasis.
    Wang T; Tao J; Wang B; Jiang T; Zhao X; Yu Y; Meng X
    Adv Healthc Mater; 2024 Feb; 13(4):e2302597. PubMed ID: 37941492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KDM1A inhibition is effective in reducing stemness and treating triple negative breast cancer.
    Zhou M; Venkata PP; Viswanadhapalli S; Palacios B; Alejo S; Chen Y; He Y; Pratap UP; Liu J; Zou Y; Lai Z; Suzuki T; Brenner AJ; Tekmal RR; Vadlamudi RK; Sareddy GR
    Breast Cancer Res Treat; 2021 Jan; 185(2):343-357. PubMed ID: 33057995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells.
    Jagust P; Alcalá S; Sainz Jr B; Heeschen C; Sancho P
    World J Stem Cells; 2020 Nov; 12(11):1410-1428. PubMed ID: 33312407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist.
    Prud'homme GJ; Glinka Y; Toulina A; Ace O; Subramaniam V; Jothy S
    PLoS One; 2010 Nov; 5(11):e13831. PubMed ID: 21072210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ce6-Conjugated and polydopamine-coated gold nanostars with enhanced photoacoustic imaging and photothermal/photodynamic therapy to inhibit lung metastasis of breast cancer.
    Li Z; Yang F; Wu D; Liu Y; Gao Y; Lian H; Zhang H; Yin Z; Wu A; Zeng L
    Nanoscale; 2020 Nov; 12(43):22173-22184. PubMed ID: 33135699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphosulindac (OXT-328) selectively targets breast cancer stem cells in vitro and in human breast cancer xenografts.
    Zhu C; Cheng KW; Ouyang N; Huang L; Sun Y; Constantinides P; Rigas B
    Stem Cells; 2012 Oct; 30(10):2065-75. PubMed ID: 22653497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyaluronic Acid-Functionalized Gold Nanorods with pH/NIR Dual-Responsive Drug Release for Synergetic Targeted Photothermal Chemotherapy of Breast Cancer.
    Xu W; Qian J; Hou G; Suo A; Wang Y; Wang J; Sun T; Yang M; Wan X; Yao Y
    ACS Appl Mater Interfaces; 2017 Oct; 9(42):36533-36547. PubMed ID: 28975790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells.
    Zhou H; Yu C; Kong L; Xu X; Yan J; Li Y; An T; Gong L; Gong Y; Zhu H; Zhang H; Yang X; Li Y
    Oncogene; 2019 May; 38(18):3371-3386. PubMed ID: 30635656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.